Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Scientific Reports
|
March 7, 2019
Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer
Yi Li, Yannan Zhao, Chengcheng Gong, et al.
Annals of Palliative Medicine
|
October 21, 2021
Phase II study of chidamide in combination with cisplatin in patients with metastatic triple-negative breast cancer
Yanchun Meng, Juan Jin, Chengcheng Gong, et al.
International Journal of General Medicine
|
May 19, 2021
Prediction of Pretreatment 18F-FDG-PET/CT Parameters on the Outcome of First-Line Therapy in Patients with Metastatic Breast Cancer
Yi Li, Cheng Liu, Bibo Wang, et al.
Cancers
|
August 26, 2022
Temporal Heterogeneity of HER2 Expression and Spatial Heterogeneity of <sup>18</sup>F-FDG Uptake Predicts Treatment Outcome of Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer
Chengcheng Gong, Cheng Liu, Zhonghua Tao, et al.
Therapeutic Advances in Medical Oncology
|
November 24, 2025
Development and validation of nomograms of outcomes for first-line platinum-based chemotherapy for metastatic triple-negative breast cancer: patient-level analysis of five prospective clinical trials in China
Chengcheng Gong, Ting Li, Yifan Chen, et al.
Scientific Reports
|
July 28, 2017
A preliminary study of <sup>18</sup>F-FES PET/CT in predicting metastatic breast cancer in patients receiving docetaxel or fulvestrant with docetaxel
Chengcheng Gong, Zhongyi Yang, Yifei Sun, et al.
BMC Cancer
|
November 3, 2021
Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
Yizhao Xie, Chengcheng Gong, Jian Zhang, et al.
The Oncologist
|
November 16, 2020
Everolimus-Related Pneumonitis in Patients with Metastatic Breast Cancer: Incidence, Radiographic Patterns, and Relevance to Clinical Outcome
Chengcheng Gong, Qin Xiao, Yi Li, et al.
Cancer Research and Treatment
|
March 14, 2023
Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study
Xin Liu, Chengcheng Gong, Jieyun Zhang, et al.
Scientific Reports
|
February 10, 2019
Treatment after Progression on Fulvestrant among Metastatic Breast Cancer Patients in Clinical Practice: a Multicenter, Retrospective Study
Yizhao Xie, Yannan Zhao, Chengcheng Gong, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Scientific Reports
|
March 7, 2019
Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer
Yi Li, Yannan Zhao, Chengcheng Gong, et al.
Annals of Palliative Medicine
|
October 21, 2021
Phase II study of chidamide in combination with cisplatin in patients with metastatic triple-negative breast cancer
Yanchun Meng, Juan Jin, Chengcheng Gong, et al.
International Journal of General Medicine
|
May 19, 2021
Prediction of Pretreatment 18F-FDG-PET/CT Parameters on the Outcome of First-Line Therapy in Patients with Metastatic Breast Cancer
Yi Li, Cheng Liu, Bibo Wang, et al.
Cancers
|
August 26, 2022
Temporal Heterogeneity of HER2 Expression and Spatial Heterogeneity of <sup>18</sup>F-FDG Uptake Predicts Treatment Outcome of Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer
Chengcheng Gong, Cheng Liu, Zhonghua Tao, et al.
Therapeutic Advances in Medical Oncology
|
November 24, 2025
Development and validation of nomograms of outcomes for first-line platinum-based chemotherapy for metastatic triple-negative breast cancer: patient-level analysis of five prospective clinical trials in China
Chengcheng Gong, Ting Li, Yifan Chen, et al.
Scientific Reports
|
July 28, 2017
A preliminary study of <sup>18</sup>F-FES PET/CT in predicting metastatic breast cancer in patients receiving docetaxel or fulvestrant with docetaxel
Chengcheng Gong, Zhongyi Yang, Yifei Sun, et al.
BMC Cancer
|
November 3, 2021
Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
Yizhao Xie, Chengcheng Gong, Jian Zhang, et al.
The Oncologist
|
November 16, 2020
Everolimus-Related Pneumonitis in Patients with Metastatic Breast Cancer: Incidence, Radiographic Patterns, and Relevance to Clinical Outcome
Chengcheng Gong, Qin Xiao, Yi Li, et al.
Cancer Research and Treatment
|
March 14, 2023
Clinicopathological Analysis and Treatment of Adult Patients with Inflammatory Myofibroblastic Tumor: A 15-Year Single- Center Study
Xin Liu, Chengcheng Gong, Jieyun Zhang, et al.
Scientific Reports
|
February 10, 2019
Treatment after Progression on Fulvestrant among Metastatic Breast Cancer Patients in Clinical Practice: a Multicenter, Retrospective Study
Yizhao Xie, Yannan Zhao, Chengcheng Gong, et al.
Page
of 5